Annual Results Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
505.66
510.61
307.83
231.34
319.11
256.39
Shareholder's Funds
505.66
510.61
307.83
231.34
319.11
256.39
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
5.59
5.64
3.15
2.65
1.23
0.00
Secured Loans
5.59
5.64
3.15
2.65
1.23
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
17.06
20.63
13.11
14.78
18.04
15.2
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
17.06
20.63
13.11
14.78
18.04
15.20
Current Liabilities
Trade Payables
11.16
4.39
3.52
3.32
4.76
1.79
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
43.98
29.15
18.95
15.73
16.34
16.74
Total Liabilities
566.71
560.38
339.89
261.85
353.49
288.33
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
54.29
57.19
43.60
43.08
34.28
8.92
Less: Accumulated Depreciation
21.28
16.59
11.93
7.73
5.33
3.84
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
33.01
40.61
31.66
35.35
28.95
5.07
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
111.38
80.58
10.95
4.91
67.65
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
9.19
4.26
0.68
1.08
0.60
0.60
Total Non-Current Assets
153.58
125.45
43.30
41.34
97.21
5.68
Current Assets Loans & Advances
Current Investments
342.41
275.54
39.12
161.20
94.78
0.00
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
0.00
0.00
0.00
0.00
0.05
1.49
Cash and Bank
60.24
149.34
249.11
52.35
153.00
276.73
Other Current Assets
402.65
424.88
288.23
214.25
247.82
278.21
Short Term Loans and Advances
0.00
0.00
0.00
0.70
0.00
0.00
Total Current Assets
413.13
434.93
296.59
220.51
256.28
282.66
Net Current Assets (Including Current Investments)
369.15
405.78
277.64
204.78
239.94
265.91
Total Current Assets Excluding Current Investments
413.13
434.93
296.59
220.51
256.28
282.66
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
566.71
560.38
339.89
261.85
353.49
288.33
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
5.59
5.64
3.15
2.65
1.23
0.00
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
Compare Balance Sheet Results of 4D Molecular Therapeutics, Inc.
Figures in Million
Consolidated - Balance Sheet Results
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
505.66
154.49
351.17
227.31%
Shareholder's Funds
505.66
154.49
351.17
227.31%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
5.59
3.57
2.02
56.58%
Secured Loans
5.59
3.57
2.02
56.58%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
17.06
21.75
-4.69
-21.56%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
17.06
21.75
-4.69
-21.56%
Current Liabilities
Trade Payables
11.16
3.24
7.92
244.44%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
43.98
16.45
27.53
167.36%
Total Liabilities
566.71
192.69
374.02
194.10%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
54.29
15.45
38.84
251.39%
Less: Accumulated Depreciation
21.28
2.76
18.52
671.01%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
33.01
12.69
20.32
160.13%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
111.38
1.63
109.75
6,733.13%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
9.19
0.02
9.17
45,850.00%
Total Non-Current Assets
153.58
14.34
139.24
970.99%
Current Assets Loans & Advances
Current Investments
342.41
16.96
325.45
1,918.93%
Inventories
0
0
0.00
0.00%
Sundry Debtors
0
0
0.00
0.00%
Cash and Bank
60.24
154.47
-94.23
-61.00%
Other Current Assets
402.65
171.43
231.22
134.88%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
413.13
178.35
234.78
131.64%
Net Current Assets (Including Current Investments)
369.15
161.89
207.26
128.03%
Total Current Assets Excluding Current Investments
413.13
178.35
234.78
131.64%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
566.71
192.69
374.02
194.10%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
5.59
3.57
2.02
56.58%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Analysis not available as Data has been published for only 1 period
Annual - Investments
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Analysis not available as Data has been published for only 1 period
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
